about
Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural ProductsGlutathionylated products of lipid peroxidation: A novel mechanism of adipocyte to macrophage signalingCase report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutationEnhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.The relative merits of therapies being developed to tackle inappropriate ('self'-directed) complement activationContribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation.Complement activation and effect of eculizumab in scleroderma renal crisis.Incidence and risk factors of pleural effusions in patients with POEMS syndrome.Modulators of complement activation: a patent review (2008 - 2013).Complement deficiencies in systemic lupus erythematosus.Vasculitides and the Complement System: a Comprehensive Review.Toward a unified biosignature for tuberculosisProteomic Profiling Analysis Reveals a Link between Experimental Autoimmune Uveitis and Complement Activation in Rats.Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus--a systematic review.The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.Antigen arrays for profiling autoantibody repertoires.Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis.A pathogenic role of complement in arterial hypertension and hypertensive end organ damage.Autoimmune and Inflammatory Manifestations in 247 Patients with Primary Immunodeficiency-a Report from the Slovenian National Registry.Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis.A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.The mammalian complement system as an epitome of host-pathogen genetic conflicts.Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis.Mannan-Binding Lectin-Associated Serine Protease 1/3 Cleavage of Pro-Factor D into Factor D In Vivo and Attenuation of Collagen Antibody-Induced Arthritis through Their Targeted Inhibition by RNA Interference-Mediated Gene Silencing.Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle.Complement C3 is a novel modulator of the anti-FVIII immune response.C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.Inhibition of Macrophage Complement Receptor CRIg by TRIM72 Polarizes Innate Immunity of the Lung.Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.Targeting of Liver Mannan-Binding Lectin-Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis
P2860
Q26783178-19103381-A75A-4A13-A5A2-CA52ADD99683Q33946414-F63D0A61-AEAF-4813-A804-6A8828A4DF85Q35556372-304026BE-EB5D-4659-9B80-15ECC64F6CB3Q35677937-3DFECA17-5509-4E6A-853E-CE2FB8ABB705Q36237416-07EB38D2-0798-4E07-B159-7A55C0E1050DQ36643354-5B8CE4F6-0DEB-4265-8B64-8E20A7147B02Q36913772-048E4BF9-91A5-4645-8AE5-4345AFF756DFQ37403301-378C9B79-0B48-4CE9-9153-ACC8D945FB24Q37605730-31B4249F-18B5-4E46-BA71-D767308AEFC3Q38187361-FC988395-11A1-4D19-8CEF-CA07CB34D0BAQ38196860-F58E25DD-9D93-45C5-B4C9-FCBA7FEFB9B6Q38210887-62584954-E60E-475C-8274-98E79278E186Q38259908-3A6AD776-B2B1-44C2-9E9B-49869549151DQ38262415-0442D004-8C07-43D6-96C0-A26B5E426D92Q38436935-61729478-F754-4899-9FB7-7C8BCA28E889Q38627179-90B4DC9C-3FF4-4003-86AF-47F3629C14FDQ38650723-D1A04BBA-5537-44D3-B15E-3215CD8FCA22Q38812946-A2B4119B-F160-42AC-9EFC-CBAA19CF7D9AQ38904200-D8092019-A516-4084-8E40-B1906DDC900BQ39041868-28E8A98F-4DA5-4E30-901A-359B22CF930EQ39434075-8602A7AB-346A-4344-80B6-E938E0873509Q39903023-42622BCC-16CE-41E5-9921-166602D09232Q40734548-559929E8-096C-4320-B008-D9525CC5FB8DQ40808577-9D9EEA89-6F09-408B-82DD-D771D63CB101Q41833477-FB612058-48B3-4998-96BD-71C4F78EC0B0Q42750928-BC1BDEC4-F4C9-4A6A-8544-017CA4F7DCB0Q43734009-848F8251-ED00-4EA7-8F8B-A1B0EF8AF201Q45874563-392E2773-9DC6-4876-B418-978E7D431FD7Q47129297-E4FA0A62-025E-4E36-A021-AC836D7A84E6Q47264775-3F03E3DB-C771-45AF-9810-085864C9E10CQ52309382-6ACB17FF-A805-4B03-8629-815E45C063E1Q52327307-BBD5D18F-AC80-4C2C-BB06-BA68ACFA745DQ54217096-E17CF5F6-717E-45F4-834F-1AABAFD60183Q55250588-00D7848B-8A1D-47AB-9EED-455840BD13C3Q58770443-0F9455B9-B649-42AD-9B6F-FF1919445ABD
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Complement and autoimmunity.
@en
Complement and autoimmunity.
@nl
type
label
Complement and autoimmunity.
@en
Complement and autoimmunity.
@nl
prefLabel
Complement and autoimmunity.
@en
Complement and autoimmunity.
@nl
P2093
P2860
P1433
P1476
Complement and autoimmunity.
@en
P2093
Eleonora Ballanti
Elisabetta Greco
Gioia Di Muzio
Marta Ballanti
Roberto Perricone
P2860
P2888
P304
P356
10.1007/S12026-013-8422-Y
P577
2013-07-01T00:00:00Z
P5875
P6179
1035545366